WBA - Walgreens Boots Alliance, Inc.
| Previous Close | 54.57 |
| Open | 54.39 |
| Bid | 55.09 x 1000 |
| Ask | 55.11 x 800 |
| Day's Range | 54.50 - 55.94 |
| 52 Week Range | 49.03 - 86.31 |
| Volume | 4,145,789 |
| Avg. Volume | 5,101,353 |
| Market Cap | 49.973B |
| Beta (3Y Monthly) | 0.82 |
| PE Ratio (TTM) | 10.80 |
| EPS (TTM) | 5.11 |
| Earnings Date | Oct 28, 2019 |
| Forward Dividend & Yield | 1.83 (3.35%) |
| Ex-Dividend Date | 2019-08-19 |
| 1y Target Est | 57.10 |
- MarketWatch
Walgreens Boots, Pfizer share gains contribute to Dow's nearly 75-point jump
DOW UPDATE Shares of Walgreens Boots and Pfizer are seeing strong returns Friday morning, propelling the Dow Jones Industrial Average into positive territory. Shares of Walgreens Boots (WBA) and Pfizer (PFE) are contributing to the blue-chip gauge's intraday rally, as the Dow (DJIA) was most recently trading 72 points, or 0.
- American City Business Journals
FedEx partners with Wing, Walgreens for drone deliveries
Memphis-based FedEx Corp. announced Thursday, Sept. 19 that Wing Aviation LLC — a subsidiary of Alphabet — is working with FedEx Express and Walgreens to launch a drone delivery service. The pilot program is set to take to the air in Christiansburg, Virginia in October and will be run as part of the U.S. Department of Transportation’s Unmanned Aircraft System Integration Pilot Program (IPP). This is FedEx’s latest innovative attempt to tackle last-mile delivery.
- Business Wire
Walgreens Boots Alliance Schedules Fourth Quarter and Fiscal 2019 Earnings Announcement for October 28, 2019
Walgreens Boots Alliance, Inc. (WBA) will release its fourth quarter and fiscal 2019 earnings results at 7 a.m. Eastern time Monday, October 28, 2019 followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time. The conference call will be simulcast through the Walgreens Boots Alliance investor relations website at: http://investor.walgreensbootsalliance.com. A replay of the conference call will be archived on the website for 12 months after the call.
- Investor's Business Daily
This Dow Jones Retail Giant Is About To Test Deliveries Via Drone
Walgreens and FedEx will partner with Google Wing on drone deliveries of packages and goods. Walgreens stock and FedEx stock rose.
- Bloomberg
Aspirin-by-Drone Closer in Alphabet-Walgreens Delivery Test
(Bloomberg) -- One of the nation’s largest drug store chains and a shipping service giant are joining forces, with Alphabet Inc.’s Wing to begin a first-of-its-kind drone delivery service in October.Walgreens, FedEx Corp. and Wing, an offshoot of Google that was the first U.S. drone operator to receive partial certification as an airline, will begin the exploratory deliveries in the small town of Christiansburg, Virginia, the companies said in an announcement Thursday.The companies aim to go beyond the small-scale delivery demonstrations that have occurred so far in the U.S., typically under controlled environments conducted over short ranges, they said.“Wing has spent the last seven years developing a delivery drone and navigation system for this purpose,” Chief Executive Officer James Ryan Burgess said in the release. “By delivering small packages directly to homes through the air in minutes, and making a wide range of medicine, food and other products available to customers, we will demonstrate what we expect safer, faster, cleaner local delivery to look like in the future.”Read more: Amazon Poised to Test Chopper-Plane Mashup for Drone DeliveriesThe announcement is a sign of the rapid maturation of the drone industry, as multiple titans of industry race to find their place in what could become a transforming technology. At the same time, the U.S. government hasn’t created a regulatory structure or formal safety standards for small, low-flying drone operations, so such demonstrations continue to be conducted using waivers to existing rules.Wing has conducted demonstrations of how its deliveries would work before, including lowering a Popsicle to a toddler in Virginia last year. But the project with Walgreens and FedEx is designed to send actual merchandise to customers on a far bigger scale.The demonstration project is being conducted near the campus of Virginia Tech in Blacksburg and is associated with the Mid-Atlantic Partnership, one of the groups selected by the U.S. government as testing entities for drone commerce. While there is growing demand for using drones to deliver goods and to perform many industrial functions, the Federal Aviation Administration is still in the process of developing regulations to govern them.Robotic RaceWing is one of the leading companies in the race toward having robotic unmanned craft zip through the sky to people’s homes to drop off goods, and has received waivers to allow longer-range flights.Amazon.com Inc. and United Parcel Service Inc. are also developing their delivery services. A number of smaller companies, including Flirtey Inc. and Zipline International Inc., are either doing demonstration projects or have made deliveries in other countries.The partnership between Wing, Walgreens and FedEx has benefits for all three in the race to exploit the drone economy.Walgreens, a division of Walgreens Boots Alliance Inc., and other large drugstore chains have seen their sales chipped away at by Amazon and other online retailers, as the convenience of a brick-and-mortar pharmacy a short drive away has been supplanted by a package delivered to a customer’s front door. Amazon has also moved into the prescription drug business, offering patients conveniently-packaged pills through its PillPack unit.Drugstores Fight BackIn response, the drugstore chains have begun offering competing services to defend themselves. Walgreens offers a delivery service for prescriptions, and has partnered with FedEx to use its stores as package drop-off points. It’s also partnered with Kroger Co. on a pilot program for customers to pick up groceries at Walgreens stores.The partnership with Wing gives FedEx leverage to compete against UPS, which is using the small flying devices for revenue-generating health-care deliveries, such as blood samples, within a hospital campus in North Carolina.UPS is also seeking FAA authorization to operate like a small airline and expects to get that designation soon. UPS Chief Executive Officer David Abney has said the focus of drone deliveries would be the health-care industry at first, and then expand from there.(Updates with other companies in ninth paragraph.)\--With assistance from Drew Armstrong.To contact the reporters on this story: Alan Levin in Washington at alevin24@bloomberg.net;Thomas Black in Dallas at tblack@bloomberg.netTo contact the editors responsible for this story: Jon Morgan at jmorgan97@bloomberg.net, Elizabeth Wasserman, Ros KrasnyFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- American City Business Journals
Walgreens and FedEx to test delivery by drone
Walgreens said it's teaming with drone maker Wing in a test to deliver packages to residents of Christianburg, Virginia beginning next month.
- MarketWatch
Walgreens testing drone delivery with Alphabet company, Wing
Walgreens Boots Alliance Inc. said Thursday that it has partnered with Wing Aviation LLC, an Alphabet Inc. company, to test drone delivery of health and wellness items, food and beverage, and more. Items can be ordered on the Wing app. Walgreens will make 100 items available, as well as "packs" which will offer a number of items from a specific category, like baby or allergy. Prescriptions will not be available for drone delivery. Wing is the first drone operator to get Federal Aviation Administration certification as an air carrier, according to the announcement. The delivery service, which will bring purchases to shoppers in minutes, will be available to residents of Christiansburg, Va. starting next month. Wing has been working with Virginia Tech in Blacksburg, located near Christiansburg, on drone delivery. Walgreens stock has fallen nearly 20% for the year to date while the S&P 500 index is up 20.2% for the period.
- Business Wire
Walgreens Will Be First Retailer in U.S. to Test On-Demand Drone Delivery Service with Wing
Walgreens and Wing, a member of the Alphabet family of companies, are partnering on an industry first that will offer unparalleled speed and convenience of “store to door” delivery of health and wellness, food and beverage and convenience items – via state-of-the-art drone technology – in minutes. Walgreens, with a heritage of innovation in pharmacy and retail, and Wing Aviation LLC, the first drone operator certified as an air carrier by the Federal Aviation Administration earlier this year, will begin offering drone delivery service to eligible residents of Christiansburg, Virginia beginning next month.
- Business Wire
Drone Deliveries Coming Soon, as Wing Unveils Plans for First-of-its-Kind Trial with FedEx and Walgreens
Wing Aviation LLC, an Alphabet company, is collaborating with FedEx Express and Walgreens to launch a first-of-its-kind drone delivery service in Christiansburg, Virginia next month. The pilot program will demonstrate the many benefits of drone delivery to communities by exploring methods to enhance last-mile delivery service, improve access to health care products, and create a new avenue of growth for local businesses.
- TheStreet.com
Walgreens Testing On-Demand Drone Delivery with Alphabet's Wing Aviation
The pilot program, set for next month in Christiansburg in western Virginia, will offer store-to-door delivery of the drugstore chain's products.
- MarketWatch
Dow's 75-point fall led by losses for shares of Dow Inc., Walgreens Boots
DOW UPDATE Dragged down by negative returns for shares of Dow Inc. and Walgreens Boots, the Dow Jones Industrial Average is declining Wednesday afternoon. The Dow (DJIA) was most recently trading 79 points, or 0.
- MarketWatch
Travelers, Walgreens Boots share losses contribute to Dow's 75-point fall
DOW UPDATE Dragged down by negative returns for shares of Travelers and Walgreens Boots, the Dow Jones Industrial Average is down Wednesday morning. Shares of Travelers (TRV) and Walgreens Boots (WBA) have contributed to the index's intraday decline, as the Dow (DJIA) was most recently trading 74 points lower (-0.
- InvestorPlace
Why Rite Aid Stock Will Probably Underperform Alternatives
There's an intriguing case for Rite Aid (NYSE:RAD) stock at the moment. For a long time, bulls have been awaiting a turnaround that can boost Rite Aid stock, and a new CEO has finally come on board. Meanwhile, with the RAD stock price down over 95% from its early 2017 highs, the stock's valuation seems like it should be reasonable.Source: J. Michael Jones / Shutterstock.com And there is an intriguing, albeit high-risk, positive case for RAD stock at these levels.The current RAD stock price of $7.50 indicates a market cap of just under $400 million. The company's net debt (adjusted for the pending sale of two distribution centers) is over $3.2 billion. If the company's enterprise value of roughly $3.6 billion rises by just 10%, Rite Aid stock will almost double.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut I've been a longtime bear on RAD stock for reasons that go to the heart of the current bull case. The easy bull argument is that former CEO John Standley ran Rite Aid into the ground. Certainly, the revised deal with Walgreens (NASDAQ:WBA) was a massive disappointment. But the pressures on Rite Aid are the same pressures facing the rest of the industry.And so it's a bit too simplistic to believe that a new CEO can simply "fix" Rite Aid all that quickly amid the pressures on the sector. Meanwhile, the company's debt creates a major risk to Rite Aid stock going forward. Much like General Electric (NYSE:GE), a popular turnaround pick, new leadership can help RAD stock. But there are significant obstacles that add risk to the company's outlook. * 7 Momentum Stocks to Buy On the Dip Moreover, there are other ways, besides buying RAD stock, to bet on the turnaround of the sector. At the very least, those who are bullish on RAD stock should consider those options. Not Just Rite Aid's ProblemIt's important to put the performance of Rite Aid stock in the context of the pharmacy space. The entire industry is struggling right now. Fred's (NASDAQ:FRED), which was going to buy Rite Aid stores as part of the original Walgreens takeover, just filed for bankruptcy. Walgreens stock touched a five-year low last month. CVS Health (NYSE:CVS) bounced off its lowest levels in six years this spring.The RAD stock price has fallen further than other pharmacy equities. But that's because Rite Aid has more debt than its peers.In fact, since the beginning of 2018, Rite Aid stock has fallen 81%. But its enterprise value (its market cap plus the face value of its debt) is down only 22%. Over the same period, Walgreens' EV has dropped almost 20%, but its shares are down only 24%.It's clear that the entire sector is struggling with pressures. Reimbursement rates from insurance companies are falling. And sales of OTC products, perhaps due to competition from the likes of Amazon.com (NASDAQ:AMZN), remain weak.Those pressures, combined with higher fixed costs, have dragged down the sector's profits. Indeed, the operating profit of Walgreens' U.S. pharmacy business fell in the third quarter. Should Investors Buy CVS or Walgreens Instead of Rite Aid Stock?For RAD stock to finally rally, those industry pressures have to ease. But if that happens, investors can benefit by buying CVS or Walgreens instead. In terms of EV/EBITDA, Rite Aid stock is only modestly cheaper than CVS and Walgreens. As a result, investors would likely be better off buying one of the larger companies, which are big enough to muddle through if the environment doesn't improve.In an uber-bullish scenario, Rite Aid stock will no doubt outperform its peers (as it did after the financial crisis). That's because not many shares of RAD stock are available, so Rite Aid stock price can jump tremendously if its EBITDA increases and its free cash flow and net income move into the black from their current stagnation.But if the sector remains stable, Rite Aid stock will likely continue to underperform. And with $3 billion in debt due in 2023, and the company's net debt over six times its annual EBITDA, RAD may not be able to refinance.Rite Aid stock will outperform in a bullish scenario if the industry's pressures finally ease. In any other environment, Walgreens or CVS will likely do better. So investors who want to bet on the industry have to at least consider buying the shares of those larger operators instead. What Level Does the RAD Stock Price Need to Reach to Outperform Rite Aid's Bonds?There's another option to consider: Rite Aid's bonds. Like the RAD stock price, the prices of Rite Aid's bonds are at multi-year lows.The 6.125% bonds that mature in April 2023 have a current price of 79 and an annual yield to maturity of 13.7%. Longer-dated issues are potentially more attractive. The 7.7% February 2027 bonds are priced at 50, with a YTM of 21.2%.The 6.875% bonds that mature in 2028 have a similar price, with a yield to maturity of 18%.The bonds are less risky than Rite Aid stock, since secured bonds may have some value even if RAD goes bankrupt.And it's important to realize that RAD stock needs to climb substantially just to outperform those bonds. To top the April 2023 bonds, RAD stock price would need to reach $12. To beat the 2027 bonds, the RAD stock price would need to soar over 320%.The bond prices have an impact on Rite Aid stock because high demand for the bonds may cause demand for the equity to be low. And it's worth noting for near-term traders that the bond prices haven't moved lately, even as the RAD stock price has bounced 50% off its August lows. Consequently, the bonds are more attractive than they were a month ago.In the most bullish scenario, Rite Aid stock will outperform Rite Aid's debt. It will also outperform CVS, and Walgreens, and probably over 90% of the stocks in the market. The sheer size of the company's debt is why RAD stock has fallen so far - and why RAD stock can soar if it's finally able to lower its debt.But there's a long path to that bullish scenario, and some outside help is needed. And in anything less than a blue-sky outcome, investors likely will do better if they buy alternatives to Rite Aid stock.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Momentum Stocks to Buy On the Dip * 7 Dow Titans Breaking Higher * 5 Growth Stocks to Sell as Rates Move Higher The post Why Rite Aid Stock Will Probably Underperform Alternatives appeared first on InvestorPlace.
- Zacks
Apple Roundup: Products, Security Issues, Analyst Opinion & Trillion-Dollar Valuation
Apple's new products, Goldman's reservations about the stock, iPhone security issues and its trillion-dollar valuation are the highlights of this roundup.
- Investopedia
Walgreens Stock Could Reward Bottom Fishers
Walgreens Boots Alliance stock has carved a double bottom after posting the most extreme oversold readings since the 1970s.
- Yahoo Finance
Walmart opens its first-ever medical center and one analyst thinks it's really cool
Walmart could be signaling its foray into more health services.
- Market Realist
WBA and KHC Stocks Cost Investors despite Recovery
KHC and WBA stocks have cost investors dearly. Warren Buffett’s Berkshire Hathaway has suffered for being Kraft Heinz's biggest shareholder.
- InvestorPlace
Dow Jones Today: Lacking Sizzle
Stocks meandered for much of Friday despite some encouraging consumer data, which may not be surprising given that this week was mostly impressive for riskier assets.Source: Shutterstock In a report out earlier today, the University of Michigan's initial reading of September consumer sentiment jumped to 92 from the three-year low of 89.8 last month. Additionally, another report out this morning showed retail sales in August rose 0.4% and that the July reading was revised higher."The resilient reading shows American consumers may be poised to shake off trade war and global slowdown to support the record-long economic expansion as the labor market holds up," according to Bloomberg.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Discount Retail Stocks to Buy for a Recession In recent months, I've noted many times in this space the importance of the U.S. consumer and that many of the recession calls were likely premature because the market has not absorbed material deterioration in consumer data to date. I'll stick by that thesis because the preliminary September sentiment reading seems to indicate the August result was a bump in the road, not the start of a negative trend.Today, the Nasda Composite finished lower by 0.22% while the S&P 500 dropped 0.08%. The Dow Jones Industrial Average was up 0.13%, extending its winning streak to eight days. In late trading, 16 of the Dow's 30 components were pointed higher. Pleasant Surprise for Dow Component UNHIt was interesting if not surprising to see UnitedHealth (NYSE:UNH), a frequent guest of this space, rank as one of the best-performing names in the Dow today. I say surprising because there was a democratic debate last night, an event that typically weighs on stocks like UNH. I missed the goings on, but I'll assume whatever Medicare For All talk that took place was not strident enough to derail UNH shares today.Staying with the healthcare theme, don't read too much into today's bounce in pharmacy name Walgreens Boots Alliance (NASDAQ:WBA), a consumer staples name with sizable drug price exposure, because two of the Dow's three pharmaceuticals names finished lower today. This is another hot-button issue investors need to be aware of going forward."An ambitious draft plan from House Speaker Nancy Pelosi (D-Calif.) to allow government price negotiation on a swath of expensive drugs has shifted Washington's contentious policy debate leftward at a critical point for Democratic negotiations with Senate Republicans and the White House," reports Modern Healthcare. BA Flying HigherBoeing (NYSE:BA) continued trending higher, gaining 1.06% today as the company makes progress toward getting the 737 MAX jet airborne again. A deeper analysis of that issue and other important points on Boeing stock is available here.There seems to be some momentum for Boeing getting the jet back in the skies before the end of this year, Wall Street's desired time horizon, but by the company's admission, it doesn't control the timeline."The timeline is in the hands of divided regulators around the world who must approve Boeing's proposed software fix for 737 MAX flight controls and new training materials. European regulators plan their own test flights on the changes," reports Reuters. Fighting BackWith a decline of about 2%, Apple (NASDAQ:AAPL) was the worst-performing stock in the Dow Jones Industrial Average. That's not something that happens very often, so when it does, it's fair to surmise there's a reason for the Apple weakness, albeit temporary.Goldman Sachs analyst Rod Hall cut his price target on Apple shares today to $165 from $187, saying the company's recently unveiled $4.99 per month price on the Apple + streaming TV service is aggressive and could hamper the company's earnings.Apple rebutted the analyst, saying it doesn't expect Apple + to materially impact results. Bottom Line on Dow JonesThere are just a couple of weeks left in the the third quarter, meaning another earnings season is fast-approaching. I'll leave you with a glance at some of the sectors analysts are bullish and tepid on this quarter."At the sector level, analysts are most optimistic on the Energy (66%) sector, as this sector has the highest percentage of Buy ratings. It is interesting to note that the Energy sector is projected to report the largest earnings decline of all 11 sectors in CY 2019 (-20.9%) and the largest earnings growth of all 11 sectors in CY 2020 (30.2%)," said FactSet.The research firm notes analysts are not enthusiastic about consumer staples as that sector has the lowest percentage of "buy" ratings and the highest percentage of "sell" calls.Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Big IPO Stocks From 2019 to Watch * 7 Discount Retail Stocks to Buy for a Recession * 7 Stocks to Buy Benefiting From Millennial Money The post Dow Jones Today: Lacking Sizzle appeared first on InvestorPlace.
- Yahoo Finance
SmileDirectClub must quickly show investors profits: strategists
SmileDirectClub needs to show profits quickly in the wake of its tough first day of trading, says two strategists.
- Zacks
Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes
Walgreens' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also gaining traction from a solid retail prescription market.
- Market Realist
Walgreens Stock: Deutsche Bank Recommends a ‘Sell’
Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.
- Bloomberg
Why Birchbox Isn't Focused on Women Who Love Beauty
Sep.17 -- Katia Beauchamp, Co-Founder & CEO of Birchbox discusses her company's collaboration with Walgreens and the benefits of tapping into a brick and mortar market. She speaks with speaks to Vonnie Quinn on 'Bloomberg Markets.'
- Yahoo Finance Video
SmileDirectClub tumbles on first day of trading as CFO says company is focused on 'longterm value creation'
SmileDirectClub made its trading debut today. The teeth-straightening company's stock nose-diving after opening at $20.55 a share, below its IPO price of $23 per share. Yahoo Finance's Zack Guzman & Kristin Meyers, along with Webull CEO Anthony Denier discuss.
